Daniel Karl
- Hepatology top 10%
-
- Epigenetics and DNA Methylation 4
- Cancer-related gene regulation 4
- Protein Degradation and Inhibitors 3
-
- Vascular Tumors and Angiosarcomas 3
-
- Acute Myeloid Leukemia Research 2
-
- Sarcoma Diagnosis and Treatment 4
-
- Chronic Lymphocytic Leukemia Research 2
- Genomics and Rare Diseases 1
- Co-authors
- Na ManFan LiuConcepción MartínezRamiro E. VerdúnAdnan K. MookhtiarSarah GreenblattStephen D. NimerPierre-Jacques Hamard
- Cited by
- HepatologyMolecular BiologyOncology
- Journals
- Blood (4 papers)Clinical Epigenetics (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United StatesGermanySingapore
In The Last Decade
Daniel Karl
18 papers receiving 590 citations
Peers
Comparison fields: 5 of 87
- Hepatology 76
- Molecular Biology 351
- Oncology 135
- Cancer Research 68
- Hematology 38
Countries citing papers authored by Daniel Karl
This map shows the geographic impact of Daniel Karl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Karl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Karl more than expected).
Fields of papers citing papers by Daniel Karl
This network shows the impact of papers produced by Daniel Karl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Karl. The network helps show where Daniel Karl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Karl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 22 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 1 | |
| 5 | 2020 | 45 | |
| 6 | 2020 | 35 | |
| 7 | 2019 | 34 | |
| 8 | 2019 | 1 | |
| 9 | 2018 | 142 | |
| 10 | 2018 | 12 | |
| 11 | 2018 | 1 | |
| 12 | 2017 | 38 | |
| 13 | 2014 | 26 | |
| 14 | 2012 | 34 | |
| 15 | 2012 | 8 | |
| 16 | 2011 | 108 | |
| 17 | 2010 | 66 | |
| 18 | 2010 | 1 | |
| 19 | 2010 | 21 |
About Daniel Karl
Daniel Karl is a scholar working on Genetics, Hematology, Pulmonary and Respiratory Medicine, Molecular Biology and Management of Technology and Innovation, having authored 19 papers that have together received 597 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Sarcoma Diagnosis and Treatment (4 papers), Cancer-related gene regulation (4 papers), Vascular Tumors and Angiosarcomas (3 papers), Protein Degradation and Inhibitors (3 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Genomics and Rare Diseases (1 paper). The work is most often cited by research in Hepatology (76 citations), Molecular Biology (351 citations), Oncology (135 citations), Cancer Research (68 citations) and Hematology (38 citations). Daniel Karl has collaborated with scholars based in United States, Germany and Singapore. Frequent co-authors include Na Man, Fan Liu, Concepción Martínez, Ramiro E. Verdún, Adnan K. Mookhtiar, Sarah Greenblatt, Stephen D. Nimer, Pierre-Jacques Hamard, Stéphanie Duffort and Sam S. Yoon. Their work appears in journals such as Blood, Clinical Epigenetics, International Journal of Radiation Oncology*Biology*Physics, Gastroenterology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.